Eptinezumab-jjmr Injection
Eptinezumab-jjmr injection is used to help prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Eptinezumab-jjmr injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
🔔 How should this medicine be used?
Eptinezumab-jjmr injection comes as a solution (liquid) to inject intravenously (into a vein) over 30 minutes by a doctor or nurse in a medical facility or infusion center. It is usually given every 3 months.
Your doctor may need to interrupt or stop your infusion if you experience certain side effects. Tell your doctor immediately if you experiences any of the following symptoms during your infusion: itching, rash, flushing, shortness of breath, wheezing, or face swelling.
Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.
🔔 Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
🔔 What special precautions should I follow?
Before receiving eptinezumab-jjmr injection,
- tell your doctor and pharmacist if you are allergic to eptinezumab-jjmr, any other medications, or any of the ingredients in eptinezumab-jjmr injection. Ask your pharmacist for a list of the ingredients.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.
- tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while using eptinezumab-jjmr injection, call your doctor.
🔔 What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
As of August 2020, the most expensive drug in America is Myalept, a drug used to treat leptin deficiency. A month’s worse of this drug costs $71, 306 per month, according to research from GoodRx. Myalept is known as an “orphan drug” because it’s intended to treat a rare disease.
